279 related articles for article (PubMed ID: 7722129)
1. Treatment with beta-adrenergic blocking agents after myocardial infarction: from randomized trials to clinical practice.
Viskin S; Kitzis I; Lev E; Zak Z; Heller K; Villa Y; Zajarias A; Laniado S; Belhassen B
J Am Coll Cardiol; 1995 May; 25(6):1327-32. PubMed ID: 7722129
[TBL] [Abstract][Full Text] [Related]
2. Usefulness of beta blockers in high-risk patients after myocardial infarction in conjunction with captopril and/or valsartan (from the VALsartan In Acute Myocardial Infarction [VALIANT] trial).
Califf RM; Lokhnygina Y; Velazquez EJ; McMurray JJ; Leimberger JD; Lewis EF; Diaz R; Murin J; Pfeffer MA
Am J Cardiol; 2009 Jul; 104(2):151-7. PubMed ID: 19576338
[TBL] [Abstract][Full Text] [Related]
3. Drug prescriptions after acute myocardial infarction: dosage, compliance, and persistence.
Simpson E; Beck C; Richard H; Eisenberg MJ; Pilote L
Am Heart J; 2003 Mar; 145(3):438-44. PubMed ID: 12660666
[TBL] [Abstract][Full Text] [Related]
4. Association between functional status and use and effectiveness of beta-blocker prophylaxis in elderly survivors of acute myocardial infarction.
Vitagliano G; Curtis JP; Concato J; Feinstein AR; Radford MJ; Krumholz HM
J Am Geriatr Soc; 2004 Apr; 52(4):495-501. PubMed ID: 15066062
[TBL] [Abstract][Full Text] [Related]
5. Clinical impact of local implementation of agreed guidelines for the management of patients with acute myocardial infarction.
Badano L; Cassin M; Solinas L; Burelli C; Macor F; Zanuttini D
G Ital Cardiol; 1999 Jan; 29(1):39-47. PubMed ID: 9987046
[TBL] [Abstract][Full Text] [Related]
6. Changes in rates of beta-blocker use between 1994 and 1997 among elderly survivors of acute myocardial infarction.
Heller DA; Ahern FM; Kozak M
Am Heart J; 2000 Oct; 140(4):663-71. PubMed ID: 11011343
[TBL] [Abstract][Full Text] [Related]
7. Impact of intravenous beta-blockade before primary angioplasty on survival in patients undergoing mechanical reperfusion therapy for acute myocardial infarction.
Halkin A; Grines CL; Cox DA; Garcia E; Mehran R; Tcheng JE; Griffin JJ; Guagliumi G; Brodie B; Turco M; Rutherford BD; Aymong E; Lansky AJ; Stone GW
J Am Coll Cardiol; 2004 May; 43(10):1780-7. PubMed ID: 15145099
[TBL] [Abstract][Full Text] [Related]
8. Impact of acute beta-blocker therapy for patients with non-ST-segment elevation myocardial infarction.
Miller CD; Roe MT; Mulgund J; Hoekstra JW; Santos R; Pollack CV; Ohman EM; Gibler WB; Peterson ED
Am J Med; 2007 Aug; 120(8):685-92. PubMed ID: 17679127
[TBL] [Abstract][Full Text] [Related]
9. Beta-blocker underuse in secondary prevention of myocardial infarction.
Everly MJ; Heaton PC; Cluxton RJ
Ann Pharmacother; 2004 Feb; 38(2):286-93. PubMed ID: 14742768
[TBL] [Abstract][Full Text] [Related]
10. Do the results of randomized clinical trials of cardiovascular drugs influence medical practice? The SAVE Investigators.
Lamas GA; Pfeffer MA; Hamm P; Wertheimer J; Rouleau JL; Braunwald E
N Engl J Med; 1992 Jul; 327(4):241-7. PubMed ID: 1535419
[TBL] [Abstract][Full Text] [Related]
11. Benefits of non-selective versus cardioselective beta-blockers in acute myocardial infarction in hypertensive patients.
Hansen O; Johansson BW
J Hypertens Suppl; 1993 Jun; 11(4):S55-60. PubMed ID: 8104242
[TBL] [Abstract][Full Text] [Related]
12. [Effect of combined beta-blocker and angiotensin-converting enzyme inhibitor treatment on 1-year survival after acute myocardial infarction: findings of the PRIAMHO-II registry].
Arós F; Loma-Osorio A; Vila J; López-Bescós L; Cuñat J; Rodríguez E; San José JM; Heras M; Marrugat J;
Rev Esp Cardiol; 2006 Apr; 59(4):313-20. PubMed ID: 16709383
[TBL] [Abstract][Full Text] [Related]
13. Evaluating the effect on patient outcomes of appropriate and inappropriate use of beta-blockers as secondary prevention after myocardial infarction in a medicaid population.
Fernandes AW; Madhavan SS; Amonkar MM
Clin Ther; 2005 May; 27(5):630-45. PubMed ID: 15978313
[TBL] [Abstract][Full Text] [Related]
14. Long-term compliance with beta-blockers, angiotensin-converting enzyme inhibitors, and statins after acute myocardial infarction.
Gislason GH; Rasmussen JN; Abildstrøm SZ; Gadsbøll N; Buch P; Friberg J; Rasmussen S; Køber L; Stender S; Madsen M; Torp-Pedersen C
Eur Heart J; 2006 May; 27(10):1153-8. PubMed ID: 16399775
[TBL] [Abstract][Full Text] [Related]
15. Does beta-blocker therapy improve clinical outcomes of acute myocardial infarction after successful primary angioplasty?
Kernis SJ; Harjai KJ; Stone GW; Grines LL; Boura JA; O'Neill WW; Grines CL
J Am Coll Cardiol; 2004 May; 43(10):1773-9. PubMed ID: 15145098
[TBL] [Abstract][Full Text] [Related]
16. Beta-blocker use in patients with acute myocardial infarction treated by hospitalists.
Dall L; Simmons T; Peterson S; Herndon B
Manag Care Interface; 2000 May; 13(5):61-3, 69. PubMed ID: 11067397
[TBL] [Abstract][Full Text] [Related]
17. Use of time-dependent measures to estimate benefits of beta-blockers after myocardial infarction.
Levy AR; Tamblyn RM; Abrahamowicz M; McLeod PJ; Fitchett D
Pharmacoepidemiol Drug Saf; 2004 Sep; 13(9):623-31. PubMed ID: 15362086
[TBL] [Abstract][Full Text] [Related]
18. Physician characteristics and the initiation of beta-adrenergic blocking agent therapy after acute myocardial infarction in a managed care population.
Fehrenbach SN; Budnitz DS; Gazmararian JA; Krumholz HM
Am J Manag Care; 2001 Jul; 7(7):717-23. PubMed ID: 11464429
[TBL] [Abstract][Full Text] [Related]
19. The role of beta-blockers in the treatment of patients after infarction.
Pratt CM; Young JB; Roberts R
Cardiol Clin; 1984 Feb; 2(1):13-20. PubMed ID: 6152718
[TBL] [Abstract][Full Text] [Related]
20. Oxprenolol in myocardial infarction survivors: brief review of the European Infarction Study results in the light of other beta-blocker post infarction trials.
Schröder R
Z Kardiol; 1985; 74 Suppl 6():165-72. PubMed ID: 2869616
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
